First Report Of Cancer Drug Gleevec As New Target Therapy For Pulmonary Hypertension
Fri, 30 Sep 2005 02:00 AM EST
... Today, German scientists of the University of Giessen Lung Center (UGLC) published a case study in the Sept. 29 issue of the New England Journal of Medicine (NEJM). The study reveals that the cancer drug Gleevec (Imatinib) may represent a promising new targeted therapy for patients suffering from pulmonary hypertension. ...
Related Topics
- Pulmonary Hypertension
- Imatinib
- Pulmonary Fibrosis
- Hypertension
- Cancer Alternative Therapy
- Pulmonary Embolism
- Cancer Radiation Therapy
- Prostate Cancer
- Radiation Therapy
- Chelation therapy
- Carcinogens
- Rehabilitation
- Natural therapy
- Natural therapies
- Clinical Trials
- Epoprostenol
- Color Therapy
- Intracranial Hypertension
- Music therapy
- Massage therapy

Not Signed In -


